Skip to main navigation Skip to search Skip to main content

Slc37a2 as a therapeutic target for osteolytic diseases

Project Details

StatusFinished
Effective start/end date1/01/1931/12/19

Funding

  • Arthritis Foundation of Australia: A$25,000.00
  • Arthritis Foundation of Australia: A$25,000.00
  • Arthritis Foundation of Australia: A$25,000.00